Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Socio-economic inequalities in occurrence and health care costs in rheumatic and musculoskeletal diseases: results from a Spanish population-based study including 1.9 million persons.

Putrik P, Ramiro S, Orueta JF, Keszei A, Alonso Moran E, Nuño Solinis R, Boonen A.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):589-594. Epub 2018 Jan 31.

2.

The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches.

Simões D, Araújo FA, Monjardino T, Severo M, Cruz I, Carmona L, Lucas R.

Rheumatol Int. 2018 May;38(5):905-915. doi: 10.1007/s00296-018-3990-8. Epub 2018 Feb 8.

PMID:
29423535
3.

Patterns and Consequences of Multimorbidity in the General Population: There is No Chronic Disease Management Without Rheumatic Disease Management.

Simões D, Araújo FA, Severo M, Monjardino T, Cruz I, Carmona L, Lucas R.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):12-20. doi: 10.1002/acr.22996. Epub 2016 Nov 17.

4.

The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.

Al Maini M, Adelowo F, Al Saleh J, Al Weshahi Y, Burmester GR, Cutolo M, Flood J, March L, McDonald-Blumer H, Pile K, Pineda C, Thorne C, Kvien TK.

Clin Rheumatol. 2015 May;34(5):819-29. doi: 10.1007/s10067-014-2841-6. Epub 2014 Dec 14. Review.

5.

Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study.

Salaffi F, De Angelis R, Grassi W; MArche Pain Prevalence; INvestigation Group (MAPPING) study.

Clin Exp Rheumatol. 2005 Nov-Dec;23(6):819-28.

PMID:
16396700
6.

Economic impact of rheumatologic disorders.

Sangha O, Stucki G.

Curr Opin Rheumatol. 1997 Mar;9(2):102-5. Review.

PMID:
9135912
8.

Impact of Chronic Diseases and Multimorbidity on Health and Health Care Costs: The Additional Role of Musculoskeletal Disorders.

van der Zee-Neuen A, Putrik P, Ramiro S, Keszei A, de Bie R, Chorus A, Boonen A.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1823-1831. doi: 10.1002/acr.22913.

9.

The burden of musculoskeletal conditions.

Palazzo C, Ravaud JF, Papelard A, Ravaud P, Poiraudeau S.

PLoS One. 2014 Mar 4;9(3):e90633. doi: 10.1371/journal.pone.0090633. eCollection 2014.

10.

Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey.

Branco JC, Rodrigues AM, Gouveia N, Eusébio M, Ramiro S, Machado PM, da Costa LP, Mourão AF, Silva I, Laires P, Sepriano A, Araújo F, Gonçalves S, Coelho PS, Tavares V, Cerol J, Mendes JM, Carmona L, Canhão H; EpiReumaPt study group.

RMD Open. 2016 Jan 19;2(1):e000166. doi: 10.1136/rmdopen-2015-000166. eCollection 2016.

11.

Prevalence of musculoskeletal disorders and rheumatic diseases in an urban community in Monagas State, Venezuela: a COPCORD study.

Granados Y, Cedeño L, Rosillo C, Berbin S, Azocar M, Molina ME, Lara O, Sanchez G, Peláez-Ballestas I.

Clin Rheumatol. 2015 May;34(5):871-7. doi: 10.1007/s10067-014-2689-9. Epub 2014 Jun 13.

PMID:
24924602
12.

Socio-economic inequalities in the incidence of four common cancers: a population-based registry study.

Tweed EJ, Allardice GM, McLoone P, Morrison DS.

Public Health. 2018 Jan;154:1-10. doi: 10.1016/j.puhe.2017.10.005. Epub 2017 Nov 10.

13.

Real-life effectiveness of spa therapy in rheumatic and musculoskeletal diseases: a retrospective study of 819 patients.

Karagülle M, Kardeş S, Karagülle MZ.

Int J Biometeorol. 2017 Nov;61(11):1945-1956. doi: 10.1007/s00484-017-1384-3. Epub 2017 May 30.

PMID:
28560466
14.

The economic burden of musculoskeletal disease in Korea: a cross sectional study.

Oh IH, Yoon SJ, Seo HY, Kim EJ, Kim YA.

BMC Musculoskelet Disord. 2011 Jul 13;12:157. doi: 10.1186/1471-2474-12-157.

15.

Health-related quality of life in multiple musculoskeletal conditions: a cross-sectional population based epidemiological study. II. The MAPPING study.

Salaffi F, De Angelis R, Stancati A, Grassi W; MArche Pain; Prevalence INvestigation Group (MAPPING) study.

Clin Exp Rheumatol. 2005 Nov-Dec;23(6):829-39.

PMID:
16396701
16.

EpiReumaPt- the study of rheumatic and musculoskeletal diseases in Portugal: a detailed view of the methodology.

Rodrigues AM, Gouveia N, da Costa LP, Eusébio M, Ramiro S, Machado P, Mourão AF, Silva I, Laires P, Sepriano A, Araújo F, Coelho PS, Gonçalves S, Zhao A, Fonseca JE, de Almeida JM, Tavares V, da Silva JA, Barros H, Cerol J, Mendes J, Carmona L, Canhão H, Branco JC.

Acta Reumatol Port. 2015 Apr-Jun;40(2):110-24.

17.

Socioeconomic variation in the burden of chronic conditions and health care provision--analyzing administrative individual level data from the Basque Country, Spain.

Orueta JF, García-Álvarez A, Alonso-Morán E, Vallejo-Torres L, Nuño-Solinis R.

BMC Public Health. 2013 Sep 22;13:870. doi: 10.1186/1471-2458-13-870.

18.

Health planning in rheumatic diseases. Elaboration of a master plan for rheumatic and musculoskeletal diseases of Catalonia.

Larrosa M, Surís X, Pueyo MJ, Auleda J, de la Puente ML.

Reumatol Clin. 2012 Mar-Apr;8(2):72-7. doi: 10.1016/j.reuma.2011.12.007. Epub 2012 Feb 16.

20.

Prevalence of musculoskeletal disorders in southeastern Iran: a WHO-ILAR COPCORD study (stage 1, urban study).

Sandoughi M, Zakeri Z, Tehrani Banihashemi A, Davatchi F, Narouie B, Shikhzadeh A, Mohammadi M, Jahantigh M, Shakiba M, Moulaei NA, Yousefi S, Rezazehi B, Shirzaei Sani E, Emamdadi A, Hoseynian M, Masoodian S, Shahbakhsh S.

Int J Rheum Dis. 2013 Oct;16(5):509-17. doi: 10.1111/1756-185X.12110. Epub 2013 Jun 20.

PMID:
24164837

Supplemental Content

Support Center